<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2020.101004</article-id><article-id pub-id-type="publisher-id">ACM-33885</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20200100000_25490361.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  双原发性甲状腺乳头状癌肺腺癌1例报告及临床思考
  Multiple Primary Carcinoma Papillary Thyroid Carcinoma and Lung Adenocarcinoma: A Case Report and Clinical Considerations
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>梁</surname><given-names>昌平</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>徐</surname><given-names>颖</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>null</addr-line></aff><aff id="aff2"><addr-line>攀枝花市中心医院核医学科，四川 攀枝花</addr-line></aff><pub-date pub-type="epub"><day>06</day><month>01</month><year>2020</year></pub-date><volume>10</volume><issue>01</issue><fpage>21</fpage><lpage>25</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    目的：深化核医学医师对多原发癌的认识，提升对分化型甲状腺癌患者胸部结节的重视度。方法：全程记录1例病理结果明确的双原发性甲状腺乳头状癌肺腺癌病例的诊治过程，查阅相关文献资料，整理、总结处置方法。结果：对于分化型甲状腺癌合并肺部结节的患者，根据目前已有的检查手段，若不能完全排除转移灶的肺部结节，这类患者需要更加勤勉地进行观察、随访。结论：核医学医师在临床工作中应充分认识多原发癌存在的可能性，采用多种检查方法提高患者肺部结节早期诊断率，不能盲目给予131-碘治疗。
    Objective: To deepen the understanding of nuclear medicine physicians on multiple primary carcinoma and to enhance the importance of pulmonary nodules in patients with differentiated thyroid carcinoma. Methods: A case of multiple primary carcinoma papillary thyroid carcinoma and lung adenocarcinoma with definite pathological results was recorded. The relevant literature was consulted and the treatment methods were summarized. Results: For patients with differentiated thyroid carcinoma complicated with pulmonary nodules, according to the existing examination methods, if the pulmonary nodules with metastases cannot be completely excluded, these patients need more diligent observation and follow-up. Conclusion: Nuclear medicine doctors should fully understand the possibility of multiple primary carcinoma in clinical work, and adopt multiple examination methods to improve the early diagnosis rate of pulmonary nodules, instead of blindly giving 131 iodine treatment. 
  
 
</p></abstract><kwd-group><kwd>多原发性，分化型甲状腺癌，肺癌, Multiple Primary</kwd><kwd> Differentiated Thyroid Carcinoma</kwd><kwd> Lung Cancer</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>双原发性甲状腺乳头状癌肺腺癌1例报告及临床思考<sup> </sup></title><p>梁昌平，徐颖</p><p>攀枝花市中心医院核医学科，四川 攀枝花</p><p>收稿日期：2019年12月20日；录用日期：2020年1月2日；发布日期：2020年1月9日</p><disp-formula id="hanspub.33885-formula33"><graphic xlink:href="//html.hanspub.org/file/4-1571124x5_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>目的：深化核医学医师对多原发癌的认识，提升对分化型甲状腺癌患者胸部结节的重视度。方法：全程记录1例病理结果明确的双原发性甲状腺乳头状癌肺腺癌病例的诊治过程，查阅相关文献资料，整理、总结处置方法。结果：对于分化型甲状腺癌合并肺部结节的患者，根据目前已有的检查手段，若不能完全排除转移灶的肺部结节，这类患者需要更加勤勉地进行观察、随访。结论：核医学医师在临床工作中应充分认识多原发癌存在的可能性，采用多种检查方法提高患者肺部结节早期诊断率，不能盲目给予131-碘治疗。</p><p>关键词 :多原发性，分化型甲状腺癌，肺癌</p><disp-formula id="hanspub.33885-formula34"><graphic xlink:href="//html.hanspub.org/file/4-1571124x6_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2020 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/4-1571124x7_hanspub.png" /> <img src="//html.hanspub.org/file/4-1571124x8_hanspub.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>多原发癌(multiple primary carcinoma，MPC)是指人体的同一器官、成对器官，同一系统不同部位、不同系统的器官发生两个或两个以上彼此无关系的原发癌，也称重复癌 [<xref ref-type="bibr" rid="hanspub.33885-ref1">1</xref>] [<xref ref-type="bibr" rid="hanspub.33885-ref2">2</xref>]。随着近年甲状腺癌的发病率增高，胸部CT的普及应用，检查出分化型甲状腺癌合并肺部结节患者增多，在131-碘治疗之前若能明确患者肺部结节性质，将对治疗方案的选择提供依据。本病例报道了1例经病理最终确诊的双原发性甲状腺乳头状癌肺腺癌，旨在加深核医学医师对分化型甲状腺癌患者肺部结节的重视度。</p></sec><sec id="s4"><title>2. 临床病例资料</title><p>患者女，63岁。因“糖尿病”于当地医院住院期间行甲状腺彩超：甲状腺右侧叶可见数个低弱回声，最大约3.5 mm &#215; 2.5 mm，甲状腺左侧叶下份可见一低弱回声，大小约6.2 mm &#215; 3.8 mm，界清，形态规则，内可见点状强回声，峡部可见一大小约5.9 mm &#215; 4.5 mm偏低回声，颈部淋巴结：双侧颈部可见数个淋巴结回声，界清，形态规则，最大约13.4 mm &#215; 3.3 mm (右)，16.4 mm &#215; 7.4 mm (左)。CDFI：可见点状血流信号。既往体健，无吸烟、饮酒史。完善相关检查，2017年11月17日于当地医院行“甲状腺左右叶改良Micolli术 + 双侧喉返神经探查术”，术后病理结果：左侧甲状腺乳头状癌，癌结节约0.6 cm (图1)。右侧甲状腺结节性甲状腺肿。颈部中央区淋巴结6枚未见癌转移。2018年1月，患者为行131-碘治疗停服左甲状腺素1月，于我科就诊，完善相关检查：游离三碘甲状腺原氨酸FT<sub>3</sub> 1.58 pmol/L，游离甲状腺素FT<sub>4</sub> 4.04 pmol/L，促甲状腺激素TSH 129.341 mIU/L；甲状腺球蛋白抗体aTG &lt; 15.0 U/mL；甲状腺球蛋白Tg 7.40 ng/mL；24 h吸131碘率：6.46%；心胸CT：1) 左肺上叶散在磨玻璃样小结节灶，大者长径约0.8 cm，右肺上叶一枚磨玻璃结节影，不除外转移，宜随诊复查。分期：T1aN0Mx。诊断剂量131-碘显像：颈部甲状腺床区可见异常放射性摄取增高影，余部位未见异常放射性摄取影。复查甲状腺球蛋白Tg 8.41 ng/mL。2018年1月18日给予治疗剂量131-碘(150 mci)清甲兼清灶治疗。5天后行治疗剂量131-碘显像：颈部甲状腺床区可见异常放射性摄取增高影，余部位未见异常放射性摄取影。2018年7月，患者于我院门诊复查心胸CT平扫：双肺上叶磨玻璃小结节影，左侧大者长径约0.8 cm，与前次比较变化不明显，建议随诊复查。2018年9月，患者因“咳嗽、咳痰1月”，当地医院行心胸CT平扫：肺部炎症、左上肺占位。为求进一步诊治，患者遂于我院胸外科住院，完善相关检查，心胸CT平扫：1) 双肺上叶散在磨玻璃小结节影，左侧大者长径约0.8 cm，与既往系列CT片比较无明显变化。2) 双侧胸膜增厚。因患者及家属强烈要求手术治疗，考虑病灶较小，术前行CT病灶穿刺定位(图2)，CT示左上肺磨玻璃小结节影，长径约0.8 cm，密度均匀，边界清楚。2018年9月11日行“胸腔镜下左上肺占位楔形切除、胸膜粘连松解、胸腔闭式引流术”，置入胸腔镜及操作器械探查见：左肺与胸壁少部分粘连，左上肺后段有一钢丝穿刺固定点，其它未见明确异常；胸腔镜下分离粘连，用腔镜直线型切割吻合器钉匣楔形较大范围切除左上肺钢丝穿刺固定点周围肺组织，取出切除肺组织，切开可见一结节样组织；术后病理结果：“左上肺”微小浸润性腺癌(贴壁型 + 乳头型) (图3)。</p><p>图1. 甲状腺乳头状癌病理图片HE 4 &#215; 10 (外院)</p><p>图2. 胸部CT病灶穿刺定位图像</p><p>图3. 肺腺癌病理图(HE10 &#215; 20)</p></sec><sec id="s5"><title>3. 讨论</title><p>多原发癌诊断标准目前多采用1932年WARREN和GATES [<xref ref-type="bibr" rid="hanspub.33885-ref3">3</xref>] 提出的标准：1) 每一肿瘤均证实为恶性；2) 具有不同的组织类型；3) 必须排除转移或复发肿瘤 [<xref ref-type="bibr" rid="hanspub.33885-ref4">4</xref>]。多原发癌发病率差异很大，国外报告癌症患者中多原发癌的发病率为0.73%~11.7% [<xref ref-type="bibr" rid="hanspub.33885-ref4">4</xref>] [<xref ref-type="bibr" rid="hanspub.33885-ref5">5</xref>]，国内约2.67% [<xref ref-type="bibr" rid="hanspub.33885-ref4">4</xref>] [<xref ref-type="bibr" rid="hanspub.33885-ref6">6</xref>]，近年来多原发癌发病率不断上升 [<xref ref-type="bibr" rid="hanspub.33885-ref7">7</xref>] [<xref ref-type="bibr" rid="hanspub.33885-ref8">8</xref>]。其发病原因可能与不良生活习惯、饮食 [<xref ref-type="bibr" rid="hanspub.33885-ref9">9</xref>]，基因突变 [<xref ref-type="bibr" rid="hanspub.33885-ref10">10</xref>]，年龄的增长，人体免疫水平的降低，肿瘤免疫，合并代谢综合征以及一些医源性因素，如放化疗等有关 [<xref ref-type="bibr" rid="hanspub.33885-ref4">4</xref>] [<xref ref-type="bibr" rid="hanspub.33885-ref11">11</xref>]。</p><p>本案例报道回顾了1例双原发性甲状腺乳头状癌、肺腺癌患者肺部结节的随诊及处治情况，学习重点在于增强核医学医师对分化型甲状腺癌患者肺部结节的重视度。随着高分辨率CT与低剂量CT用于体检，很多肺原位癌、肺微浸润癌被发现，对于有肿瘤病史的患者，我们更应重视患者肺部结节的情况。研究显示 [<xref ref-type="bibr" rid="hanspub.33885-ref12">12</xref>] [<xref ref-type="bibr" rid="hanspub.33885-ref13">13</xref>] [<xref ref-type="bibr" rid="hanspub.33885-ref14">14</xref>]，分化型甲状腺癌患者肿瘤发生肺部转移的概率为3%~23%，且有逐年上升趋势，早期发现肺转移并给予有效干预，可显著提高患者的十年生存率 [<xref ref-type="bibr" rid="hanspub.33885-ref14">14</xref>]。甲状腺癌的肺转移通常引起两肺微结节样或粟粒样改变 [<xref ref-type="bibr" rid="hanspub.33885-ref15">15</xref>]。转移灶多为圆形或椭圆形实性结节，大多边缘光滑 [<xref ref-type="bibr" rid="hanspub.33885-ref16">16</xref>]。</p><p>但少数分化型甲状腺癌患者肺部结节的性质，仅仅依靠CT较难判断，尚需结合血清Tg、TgAb水平、131-碘显像、PET/CT显像等检查诊断。少数分化型甲状腺癌患者肺部结节性质判断较为困难，可能跟以下因素有关：1) 肺部是分化型甲状腺癌最容易转移的部位，当转移病灶较小、孤立病灶或者病灶出现失分化时，结节有可能不摄取或较少摄取131-碘，致使131-碘显像呈阴性，若此时患者血清Tg水平较低(在无TgAb干扰的情况下)，临床医生可能较少考虑类似病灶为转移灶。但有文献报道 [<xref ref-type="bibr" rid="hanspub.33885-ref17">17</xref>] 类似的病例在PET/CT上呈高代谢，病理最终确诊为甲状腺癌转移灶；2) 患者检查出肺结节时间较短，以往未行肺部CT等相关检查，无法对结节数目、大小、形态、结节边缘、结节–肺界面、密度、结构等因子进行比较 [<xref ref-type="bibr" rid="hanspub.33885-ref18">18</xref>]。3) 少数患者有甲状腺癌转移病灶与原发性肺癌同时存在的可能性 [<xref ref-type="bibr" rid="hanspub.33885-ref19">19</xref>] [<xref ref-type="bibr" rid="hanspub.33885-ref20">20</xref>]，Ord&#243;&#241;ez NG [<xref ref-type="bibr" rid="hanspub.33885-ref21">21</xref>] 研究发现，肺腺癌和肺部转移性甲状腺乳头状癌有时可出现相似的组织学结构及生物学行为 [<xref ref-type="bibr" rid="hanspub.33885-ref22">22</xref>]，有时原发灶很难与转移灶相鉴别 [<xref ref-type="bibr" rid="hanspub.33885-ref23">23</xref>]。4) 患者肺部存在多个结节时，不除外结节性质不一致的可能性。</p><p>根据目前已有的检查手段，若不能完全排除转移灶的肺部结节，需定期复查血清Tg、TgAb，胸部CT，必要时行131-碘显像、PET/CT显像等检查协助诊断。对于其它难以定性的肺结节，可以推荐其进行随访观察，具体的随访原则参照Fleischner学会2005年推出肺实性结节处理指南 [<xref ref-type="bibr" rid="hanspub.33885-ref24">24</xref>]，2012年推出的肺内亚实性结节的推荐处理意见 [<xref ref-type="bibr" rid="hanspub.33885-ref25">25</xref>]。核医学临床医师在临床工作中应充分认识多原发性癌存在的可能性，在无法判断肺部结节性质时，切不可盲目按转移病灶给予131-碘治疗。</p></sec><sec id="s6"><title>文章引用</title><p>梁昌平,徐 颖. 双原发性甲状腺乳头状癌肺腺癌1例报告及临床思考Multiple Primary Carcinoma Papillary Thyroid Carcinoma and Lung Adenocarcinoma: A Case Report and Clinical Considerations[J]. 临床医学进展, 2020, 10(01): 21-25. https://doi.org/10.12677/ACM.2020.101004</p></sec><sec id="s7"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.33885-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">耿振英, 焦顺昌, 王甦, 等. 106例多原发癌的临床回顾性研究[J]. 世界最新医学信息文摘, 2017, 17(12): 1-2.</mixed-citation></ref><ref id="hanspub.33885-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">乔艳俊, 王红民. 同时二重异时三重癌一例[J]. 中华肿瘤杂志, 2018, 40(5): 400.</mixed-citation></ref><ref id="hanspub.33885-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Warren, S. and Gates, O. (1932) Multiple Primary Malignant Tumors: A Survey of the Literature and a Statistical Study. American Journal of Cancer, 16, 1358-1414.</mixed-citation></ref><ref id="hanspub.33885-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">孙俊杰, 李双庆. 多原发癌病因及发病机制的探索[J]. 中国全科医学, 2017, 20(9): 1136-1140.</mixed-citation></ref><ref id="hanspub.33885-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Izmajłowicz, B., Kornafel, J. and Błaszczyk, J. (2014) Multiple Neoplasms among Cervical Cancer Patients in the Material of the Lower Silesian Cancer Registry. Advances in Clinical and Experimental Medicine, 23, 433-440.  
https://doi.org/10.17219/acem/37141</mixed-citation></ref><ref id="hanspub.33885-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">付金金, 黄载伟, 林英豪, 等. 39例多原发结直肠癌的临床研究[J]. 南方医科大学学报, 2013, 33(4): 578-581.</mixed-citation></ref><ref id="hanspub.33885-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Aydiner, A., Karadeniz, A. and Uygun, K. (2000) Multiple Primary Neoplasms at a Single Institution: Differences between Synchronous and Metachronous Neoplasms. American Journal of Clinical Oncology, 23, 364-370.  
https://doi.org/10.1097/00000421-200008000-00011</mixed-citation></ref><ref id="hanspub.33885-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Adeyanju, M.A. and Ilori, A.A. (2017) Multiple Primary Tumors. Nigerian Journal of Clinical Practice, 20, 1346-1349. https://doi.org/10.4103/njcp.njcp_432_16</mixed-citation></ref><ref id="hanspub.33885-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Roukos, D.H. (2014) Genome-Wide Association Studies: How Predictable Is a Person’s Cancer Risk? Expert Review of Anticancer Therapy, 9, 389-392. https://doi.org/10.1586/era.09.12</mixed-citation></ref><ref id="hanspub.33885-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Cybulski, C., Nazarali, S. and Narod, S.A. (2014) Multiple Primary Cancers as a Guide to Eritability. International Journal of Cancer, 135, 1756-1763. https://doi.org/10.1002/ijc.28988</mixed-citation></ref><ref id="hanspub.33885-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">王婧, 李琴, 赵志海, 等. 多原发恶性肿瘤的诊疗进展[J]. 医学综述, 2011, 17(10): 1490-1492.</mixed-citation></ref><ref id="hanspub.33885-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">陈盼, 欧阳伟, 冯会娟, 等. 分化型甲状腺癌肺转移危险因素分析[J]. 广东医学, 2015, 36(9): 1405-1407.</mixed-citation></ref><ref id="hanspub.33885-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Pitoia, F., Bueno, F. and Cross, G. (2014) Long-Term Survival and Low Effective Cumulative Radioiodine Doses to Achieve Remission in Patients with 131Iodine-Avid Lung Metastasis from Differentiated Thyroid Cancer. Clinical Nuclear Medicine, 39, 784-790. https://doi.org/10.1097/RLU.0000000000000507</mixed-citation></ref><ref id="hanspub.33885-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">邓丽华. 分化型甲状腺癌肺转移的相关危险因素分析[J]. 实用中西医结合临床, 2018, 18(8): 122-124.</mixed-citation></ref><ref id="hanspub.33885-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Kaseda, K., Watanabe, K. and Sakamaki, H. (2016) Solitary Pulmonary Metastasis from Occult Papillary Thyroid Carcinoma. Thoracic Cancer, 7, 261-263. https://doi.org/10.1111/1759-7714.12295</mixed-citation></ref><ref id="hanspub.33885-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">罗亚平. 甲状腺癌肺转移: 简单中的不简单[J]. 中华核医学与分子影像杂志, 2017, 37(2): 101-102.</mixed-citation></ref><ref id="hanspub.33885-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">叶智轶, 马超, 傅宏亮, 等. 18F-FDG PET/CT显像在131I全身显像阴性的分化型甲状腺癌中的应用价值[J]. 上海交通大学学报医学版, 2016, 36(1): 76-79.</mixed-citation></ref><ref id="hanspub.33885-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">中华医学会呼吸病学分会肺癌学组, 中国肺癌防治联盟专家组. 肺结节诊治中国专家共识(2018年版)[J]. 中华结核和呼吸杂志, 2018, 41(10): 763-771.</mixed-citation></ref><ref id="hanspub.33885-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Cheng, C., Zhou, J. and Shao, X. (2017) Lung Adenocarcinoma and Pulmonary Metastases Coexist in a Patient with Papillary Thyroid Carcinoma: A Case Report. Medicine (Baltimore), 96, e9078.  
https://doi.org/10.1097/MD.0000000000009078</mixed-citation></ref><ref id="hanspub.33885-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">高洪波, 陈永辉. 甲状腺癌肺转移合并原发性肺癌一例[J]. 中华内分泌外科杂志, 2014, 8(4): 300-305.</mixed-citation></ref><ref id="hanspub.33885-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Ordóñez, N.G. (2003) The Immunohistochemical Diagnosis of Mesothelioma: A Comparative Study of Epithelioidmesothelioma and Lung Adenocarcinoma. The American Journal of Surgical Pathology, 27, 1031-1051.  
https://doi.org/10.1097/00000478-200308000-00001</mixed-citation></ref><ref id="hanspub.33885-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">郑向前, 高明, 李亦工, 等. 甲状腺乳头状癌肺转移与细支气管肺泡癌的鉴别诊断[J]. 中国肿瘤临床, 2007, 34(22): 1302-1305.</mixed-citation></ref><ref id="hanspub.33885-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Haro, A., Kuramitsu, E., Yamamoto, I., et al. (2016) A Case Report of Successful Diagnosis of a Pulmonary Nodule by a Survey of Oncogenic Mutations; Primary Lung Carcinoma or Pulmonary Metastasis? International Journal of Surgery Case Reports, 29, 176-179. https://doi.org/10.1016/j.ijscr.2016.10.076</mixed-citation></ref><ref id="hanspub.33885-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">MacMahon, H., Austin, J.H.M., Gamsu, G., et al. (2005) Guidelines for Management of Small Pulmonary Nodules Detected on CT Scans: A Statement from the Fleischner Society. Radiology, 237, 395-400.  
https://doi.org/10.1148/radiol.2372041887</mixed-citation></ref><ref id="hanspub.33885-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Naidich, D.P., Bankier, A.A., MacMahon, H., et al. (2013) Recommendations for the Management of Subsolid Pulmonary Nodules Detected at CT: A Statement from the Fleischner Society. Radiology, 266, 304-317.  
https://doi.org/10.1148/radiol.12120628</mixed-citation></ref></ref-list></back></article>